Dalasetron Mesylate Hydrate is primarily used as an antiemetic agent, particularly in the prevention and treatment of nausea and vomiting associated with chemotherapy and postoperative recovery. It works by blocking serotonin receptors in the brain and gastrointestinal tract, which are involved in triggering the vomiting reflex. This makes it effective in managing the adverse effects of cancer treatments, such as chemotherapy and radiation therapy, which often induce severe nausea and vomiting. Additionally, it is utilized in surgical settings to prevent postoperative nausea and vomiting, improving patient comfort and recovery outcomes. Its efficacy and tolerability make it a valuable option in clinical scenarios where controlling emesis is critical.